Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 8, 2018
Ethnic, Racial, and Sex Differences in Etiology, Symptoms, Treatment, and Symptom Outcomes of Patients With GastroparesisHenry P Parkman, Goro Yamada, Mark L Van Natta, et al.
Nature Communications|June 23, 2026
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver diseaseMohammad S Siddiqui, Mark L Van Natta, Margery A Connelly, et al.
Hepatology (Baltimore, Md.)|February 8, 2022
Randomized placebo-controlled trial of losartan for pediatric NAFLDMiriam B Vos, Mark L Van Natta, Niviann M Blondet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 10, 2022
Progress in Gastroparesis - A Narrative Review of the Work of the Gastroparesis Clinical Research ConsortiumPankaj J Pasricha, Madhusudan Grover, Katherine P Yates, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 16, 2018
Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver diseaseMustafa R Bashir, Tanya Wolfson, Anthony C Gamst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2017
Intragastric Meal Distribution During Gastric Emptying Scintigraphy for Assessment of Fundic Accommodation: Correlation with Symptoms of GastroparesisPerry Orthey, Daohai Yu, Mark L Van Natta, et al.
Gastroenterology|November 8, 2017
Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related DisordersPankaj J Pasricha, Katherine P Yates, Irene Sarosiek, et al.
Pageof 8